GENMAB A/S (GE9.DE) Stock Analyst Ratings

FRA:GE9 • DK0010272202

248.6 EUR
-0.1 (-0.04%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Buy % Consensus

73

ChartMill assigns a Buy % Consensus number of 73% to GE9.DE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 297.35. This target is 19.61% above the current price.
  • GE9.DE was analyzed by 26 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about GE9.DE.
  • In the previous month the buy percentage consensus was at a similar level.
  • GE9.DE was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
GE9.DE Historical Analyst RatingsGE9.DE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 10 20 30

Price Target & Forecast

Price Low Median Mean High 248.60137.49305.74297.35411.20 - -44.70% 22.99% 19.61% 65.40%

Related screens

Find peers 30% below price target
GE9.DE Current Analyst RatingGE9.DE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades

GENMAB A/S / GE9.DE FAQ

What do analysts expect the price target to be for GENMAB A/S (GE9.DE)?

26 analysts have analysed GE9.DE and the average price target is 297.36 EUR. This implies a price increase of 19.61% is expected in the next year compared to the current price of 248.6.


How do analysts rate GENMAB A/S (GE9.DE)?

The consensus rating for GENMAB A/S (GE9.DE) is 73.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.